Diagnosing mesothelioma is a complex process that requires specialized testing and careful examination. Because this rare cancer often mimics more common conditions and develops slowly over decades, identifying it accurately is crucial for planning the right treatment approach.

Who Should Seek Diagnostic Testing and When

Understanding when to seek medical attention for mesothelioma is important because early detection can improve treatment options. Anyone who has worked with or been exposed to asbestos—a group of minerals that form tiny, sharp fibers—should be particularly alert to certain warning signs. Asbestos was widely used in building materials, shipyards, and many industries throughout the 20th century before its health dangers became fully understood.^[1][2]

People who should consider diagnostic evaluation include those experiencing persistent symptoms such as chest pain, difficulty breathing, or unexplained weight loss, especially if they have a history of asbestos exposure. The challenge is that mesothelioma symptoms develop very slowly. After someone breathes in asbestos fibers, it can take 40 years or even 50 years before mesothelioma forms. This long waiting period, called the latency period, means that people exposed to asbestos decades ago may only now be developing symptoms.^[3][4]

Workers in certain occupations face higher risk and should be especially watchful. Those who mined asbestos, worked in shipbuilding, handled insulation, or worked in older buildings containing asbestos materials are at increased risk. Even family members of these workers can be at risk if they were exposed to asbestos fibers brought home on clothing.^[2][8]

It’s important to contact a doctor if you notice ongoing symptoms such as chest pain under the rib cage, a persistent cough that doesn’t go away, shortness of breath that gets worse over time, or lumps under the skin on your chest. For those with abdominal concerns, symptoms like belly pain, swelling in the abdomen, nausea, or unexplained weight loss should prompt a medical visit. These symptoms can be caused by many different conditions, but only a doctor can determine whether mesothelioma or another disease is responsible.^[1][8]

Classic Diagnostic Methods for Identifying Mesothelioma

Diagnosing mesothelioma is often difficult because it can easily be confused with other, more common diseases. The symptoms of mesothelioma overlap significantly with conditions like pneumonia, the flu, or even lung cancer. Because mesothelioma is so rare—with only about 3,300 new cases diagnosed each year in the United States—many doctors may never encounter it during their careers. This rarity contributes to frequent misdiagnosis.^[2][4]

The diagnostic process typically begins with a detailed medical history and physical examination. Your healthcare provider will ask about your work history and whether you’ve been exposed to asbestos. They will check for physical signs such as lumps under the skin, listen to your breathing, and look for fluid buildup in your chest or abdomen. This initial assessment helps doctors decide which tests to order next.^[8][10]

Imaging Tests

Imaging studies are usually the next step in diagnosing mesothelioma. A chest X-ray is often the first imaging test performed. It can show thickening of the pleura—the thin layer of tissue that lines the chest cavity and covers the lungs—or reveal calcium deposits on the pleura. X-rays can also detect if fluid has accumulated around the lungs, a condition called pleural effusion. If doctors suspect mesothelioma in the abdomen, an abdominal X-ray may be performed to check for fluid buildup in that area.^[9][10]

Computed tomography scans, commonly called CT scans, provide much more detailed images than X-rays. A CT scan creates cross-sectional pictures of your body using X-rays and computer technology. This test helps doctors determine the location and size of mesothelioma tumors and shows whether the cancer has spread to nearby structures like lymph nodes or other organs. CT scans are particularly valuable because they can reveal details that might be missed on a standard X-ray.^[9][10]

Magnetic resonance imaging (MRI) uses powerful magnets and radio waves instead of X-rays to create detailed images of soft tissues inside the body. MRI scans can be especially helpful for examining the chest and abdomen to see how far mesothelioma has spread. Some doctors also use positron emission tomography (PET) scans, which involve injecting a small amount of radioactive sugar into the body. Cancer cells absorb more of this sugar than normal cells, making them appear brighter on the scan. This helps doctors identify areas where cancer may have spread.^[10]

Biopsy Procedures

While imaging tests can suggest mesothelioma, a biopsy is the only way to confirm the diagnosis with certainty. A biopsy involves removing a small sample of tissue or fluid from the affected area so it can be examined under a microscope in a laboratory. The type of biopsy performed depends on where the suspected cancer is located.^[2][10]

One common approach is a needle biopsy, where a healthcare professional inserts a thin needle through the skin to remove fluid or a small piece of tissue from the chest or abdomen. This procedure is less invasive than surgery but may not always provide enough tissue for a definitive diagnosis. If more tissue is needed, doctors may perform a surgical biopsy. During this procedure, a surgeon makes a small incision and inserts a tube with a tiny video camera attached, allowing them to see inside the chest or abdomen. The surgeon can then pass specialized tools through the tube to collect tissue samples.^[10]

The collected tissue is sent to a laboratory where specialists examine it closely. They look for specific characteristics of mesothelioma cells and use special staining techniques called immunochemistry to distinguish mesothelioma from other types of cancer, particularly lung cancer. This distinction is crucial because treatment approaches differ significantly between mesothelioma and other cancers.^[3]

Additional Diagnostic Tests

Doctors may also perform blood tests to check for tumor markers—certain proteins that cancer cells release into the bloodstream. While these markers alone cannot diagnose mesothelioma, they can provide supporting evidence when combined with other test results.^[9]

Pulmonary function tests may be ordered to assess how well your lungs are working. These breathing tests measure how much air your lungs can hold and how quickly you can move air in and out of your lungs. Understanding your lung function helps doctors plan treatment and predict how you might respond to certain therapies.^[9]

Determining the Extent of Cancer

Once mesothelioma is confirmed, additional tests help determine how far the cancer has spread. This process, called staging, is essential for planning treatment. Staging tests may include CT scans of both the chest and abdomen, MRI scans, and PET scans. These imaging studies help doctors see whether cancer has spread to lymph nodes or distant organs.^[10]

The staging system for pleural mesothelioma ranges from stage 1 to stage 4. A lower number means the cancer is more localized and hasn’t spread far, while a higher number indicates more advanced disease with wider spread. Understanding the stage helps your healthcare team choose treatments that are most appropriate for your specific situation.^[10]

Diagnostic Testing for Clinical Trial Qualification

Clinical trials test new treatments that may help mesothelioma patients live longer or experience better quality of life. To participate in a clinical trial, patients must meet specific requirements, and diagnostic tests play a key role in determining eligibility. These tests ensure that the experimental treatment being studied is appropriate for each patient’s specific type and stage of mesothelioma.^[2]

Before enrolling in a clinical trial, patients typically undergo comprehensive diagnostic evaluations. These assessments verify the mesothelioma diagnosis, determine the exact type of mesothelioma based on cell characteristics, and establish how far the cancer has spread. Most clinical trials require confirmation through biopsy that a patient has mesothelioma rather than another type of cancer.^[3]

Imaging studies such as CT scans, MRI, or PET scans are standard requirements for clinical trial enrollment. These tests provide baseline measurements of tumor size and location. Researchers use this information to track whether the treatment being tested is working. Follow-up scans performed during the trial are compared to these initial images to see if tumors are shrinking, staying the same size, or growing.^[10]

Blood tests are also commonly required for clinical trial participation. These tests assess overall health and organ function, particularly of the liver, kidneys, and bone marrow. Blood work helps researchers ensure that patients are healthy enough to tolerate experimental treatments, which sometimes have unknown side effects. Tests may include complete blood counts, liver function tests, and kidney function tests.^[4]

Some clinical trials studying targeted therapies or immunotherapies require additional specialized testing. For instance, tissue samples from the biopsy may be tested for specific genetic markers or proteins on cancer cells. These biomarker tests help determine whether a patient’s cancer has characteristics that make it likely to respond to the particular treatment being studied. This approach, called personalized medicine, aims to match patients with treatments most likely to help them.^[2]

Performance status assessment is another important criterion for clinical trial eligibility. Doctors evaluate how well patients can carry out daily activities and how much the cancer affects their functioning. This assessment helps ensure that patients are strong enough to handle the demands of experimental treatments and frequent monitoring required in clinical trials.^[4]

Throughout a clinical trial, patients undergo regular diagnostic testing to monitor their response to treatment and watch for side effects. These ongoing assessments are crucial for patient safety and for determining whether the experimental treatment shows promise. The data collected from these tests contributes to scientific knowledge about mesothelioma and may eventually lead to new approved treatments that benefit future patients.^[2]